1Kobayashi R,Konomi M,Hasegawa K,et al.In vitro activity of Tebipenem,a new oral carbapenem antibiotic,against penicillin-nonsusceptible Stareptococcus pneumoniaae[].AntimirobAgents Chemother.2005 被引量：1
2Bronson J.J,,Barrett J.F.Recent developmentsi n antibacterial research[].Annual Reports in Medicinal Chemistry.2001 被引量：1
3Kawamoto I,,Shimoji Y,Kanno O,et al.Synthesis and structure-activ-ity relationships of novel parenteral carbapenems,CS-023(R-115685)and re-lated compounds containing an amidine moiety[].Journal of Antibiotics.2003 被引量：1
4Koda T,Abe T,Inoue H,et al.In vitro and in vivo antibacterial activities of CS-023(Ro4908463),a novel prenteral carbapenem[].AntimirobAgents Chemother.2005 被引量：1
5Isacs R.Friedl,and I.Gresser R.et al.Ertapenm1g once a day is highly effective in treatment of severe community-acquired and mixed infections[].Clini-cal Microbiology and Infections.2002 被引量：1
6Sorbera L.A,,Castaner J.Ceftobiprole/Ceftobiprole Medocaril[].Drugs of the Future.2005 被引量：1
7Ueda Y,Kanaziwa K,Eguchi K,et al.In vitro and in vivo antibacterial activity of SM-216601,a new broad-spectrum paremtavalc arbapenem[].AntimirobAgents Chemother.2005 被引量：1
